179 related articles for article (PubMed ID: 10518795)
1. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity.
Nickel R; Ott C; Dandekar T; Leippe M
Eur J Biochem; 1999 Nov; 265(3):1002-7. PubMed ID: 10518795
[TBL] [Abstract][Full Text] [Related]
2. Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.
Leippe M; Andrä J; Nickel R; Tannich E; Müller-Eberhard HJ
Mol Microbiol; 1994 Dec; 14(5):895-904. PubMed ID: 7715451
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pore-forming peptides from pathogenic and nonpathogenic Entamoeba histolytica.
Leippe M; Bahr E; Tannich E; Horstmann RD
Mol Biochem Parasitol; 1993 May; 59(1):101-9. PubMed ID: 8515772
[TBL] [Abstract][Full Text] [Related]
4. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence.
Bracha R; Nuchamowitz Y; Leippe M; Mirelman D
Mol Microbiol; 1999 Nov; 34(3):463-72. PubMed ID: 10564488
[TBL] [Abstract][Full Text] [Related]
5. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction.
Tannich E
Trans R Soc Trop Med Hyg; 1998; 92(6):593-6. PubMed ID: 10326098
[TBL] [Abstract][Full Text] [Related]
6. The pore-forming peptide of Entamoeba histolytica, the protozoan parasite causing human amoebiasis.
Leippe M; Müller-Eberhard HJ
Toxicology; 1994 Feb; 87(1-3):5-18. PubMed ID: 7512763
[TBL] [Abstract][Full Text] [Related]
7. Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica.
Leippe M; Tannich E; Nickel R; van der Goot G; Pattus F; Horstmann RD; Müller-Eberhard HJ
EMBO J; 1992 Oct; 11(10):3501-6. PubMed ID: 1396552
[TBL] [Abstract][Full Text] [Related]
8. Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.
Leippe M; Andrä J; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2602-6. PubMed ID: 8146160
[TBL] [Abstract][Full Text] [Related]
9. A homologue of the cysteine proteinase gene (ACP1 or Eh-CPp3) of pathogenic Entamoeba histolytica is present in non-pathogenic E. dispar strains.
Mirelman D; Nuchamowitz Y; Böhm-Gloning B; Walderich B
Mol Biochem Parasitol; 1996 Jun; 78(1-2):47-54. PubMed ID: 8813676
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
Ximénez C; González E; Nieves M; Magaña U; Morán P; Gudiño-Zayas M; Partida O; Hernández E; Rojas-Velázquez L; García de León MC; Maldonado H
PLoS One; 2017; 12(8):e0181962. PubMed ID: 28771523
[TBL] [Abstract][Full Text] [Related]
11. Novel putative saposin-like proteins of Entamoeba histolytica different from amoebapores.
Bruhn H; Leippe M
Biochim Biophys Acta; 2001 Sep; 1514(1):14-20. PubMed ID: 11513801
[TBL] [Abstract][Full Text] [Related]
12. Host-Parasite interactions in Entamoeba histolytica and Entamoeba dispar: what have we learned from their genomes?
Wilson IW; Weedall GD; Hall N
Parasite Immunol; 2012; 34(2-3):90-9. PubMed ID: 21810102
[TBL] [Abstract][Full Text] [Related]
13. Membrane lipid composition protects Entamoeba histolytica from self-destruction by its pore-forming toxins.
Andrä J; Berninghausen O; Leippe M
FEBS Lett; 2004 Apr; 564(1-2):109-15. PubMed ID: 15094050
[TBL] [Abstract][Full Text] [Related]
14. Pore-forming peptide of pathogenic Entamoeba histolytica.
Leippe M; Ebel S; Schoenberger OL; Horstmann RD; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7659-63. PubMed ID: 1881907
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biochemical characterization of phosphoglucomutases from Entamoeba histolytica and Entamoeba dispar.
Ortner S; Binder M; Scheiner O; Wiedermann G; Duchêne M
Mol Biochem Parasitol; 1997 Dec; 90(1):121-9. PubMed ID: 9497037
[TBL] [Abstract][Full Text] [Related]
16. Introns of Entamoeba histolytica and Entamoeba dispar.
Wilihoeft U; Campos-Góngora E; Touzni S; Bruchhaus I; Tannich E
Protist; 2001 Jul; 152(2):149-56. PubMed ID: 11545438
[TBL] [Abstract][Full Text] [Related]
17. Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite.
Leippe M
Cell; 1995 Oct; 83(1):17-8. PubMed ID: 7553868
[No Abstract] [Full Text] [Related]
18. The abundant polyadenylated transcript 2 DNA sequence of the pathogenic protozoan parasite Entamoeba histolytica represents a nonautonomous non-long-terminal-repeat retrotransposon-like element which is absent in the closely related nonpathogenic species Entamoeba dispar.
Willhoeft U; Buss H; Tannich E
Infect Immun; 2002 Dec; 70(12):6798-804. PubMed ID: 12438355
[TBL] [Abstract][Full Text] [Related]
19. Pore-forming peptide of Entamoeba histolytica. Significance of positively charged amino acid residues for its mode of action.
Andrä J; Leippe M
FEBS Lett; 1994 Oct; 354(1):97-102. PubMed ID: 7525351
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of the hexokinase isoenzyme pattern that distinguishes pathogenic Entamoeba histolytica from nonpathogenic Entamoeba dispar.
Ortner S; Clark CG; Binder M; Scheiner O; Wiedermann G; Duchêne M
Mol Biochem Parasitol; 1997 May; 86(1):85-94. PubMed ID: 9178270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
